Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of AGN208397 in the Treatment of Macular Edema Associated With Retinal Vein Occlusion (RVO)

NCT01027650 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT01027650
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01027650 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of AGN208397 in the Treatment of Macular Edema Associated With Retinal Vein Occlusion (RVO)
Lead sponsor
Allergan
Phase
Phase 1/2
Overall status
Completed
Start date
March 31, 2010
Completion date
February 28, 2013
Enrollment
121 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

macular edema, retinal vein occlusion